Ibnsina Pharma’s Acquisition of 75% stake in 3elagi Tech’s Operations in Egypt for USD 1.6 million

Lead party: Ibnsina Pharma (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: 3elagi Tech (private company) · Sector: Healthcare, Digital Health Platforms · Countries of operation: Egypt Transaction type: Investment, Exit · Asset class: Venture Capital, Corporate Transactions · Strategy: Buyout · Instrument: Ordinary Shares (Equity) · Deal…


Lead party: Ibnsina Pharma (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: 3elagi Tech (private company) · Sector: Healthcare, Digital Health Platforms · Countries of operation: Egypt

Transaction type: Investment, Exit · Asset class: Venture Capital, Corporate Transactions · Strategy: Buyout · Instrument: Ordinary Shares (Equity) · Deal amount: US$1.6m · Equity stake: 0.75% · Implied EV: US$2.1m

Lead investor/buyer: Ibnsina Pharma · Investors/buyers: Ibnsina Pharma · Sellers: Falak Startups

Legal advisers: not identified in the source record.

Source: announced 9 November 2020. Original announcement: techinafrica.com.